To Assess the Safety, Tolerability and Pharmacokinetics of INCB086550

NCT04674748 · clinicaltrials.gov ↗

PHASE1

Phase

TERMINATED

Status

3

Enrollment

INDUSTRY

Sponsor class

Stopped The study was terminated early due to a business decision.

Conditions

Solid Tumors

Interventions

DRUG: INCB086550

Sponsor

Incyte Biosciences Japan GK